Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 1, 2014, Pages 103-110

  Kofla Dłubacz, Anna ^a   Matusiewicz, Małgorzata ^a   Krzesiek, Elzbieta ^a   Noga, Leszek ^a   Iwańczak, Barbara ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Children; Metalloproteinases; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; GELATINASE B; SALAZOSULFAPYRIDINE; STEROID; STROMELYSIN; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN TISSUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; CLINICAL EVALUATION; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9;

EID: 84897498106     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: 10.17219/acem/37031     Document Type: Article

References (26)

1. Meijer MJ, Mieremet-Ooms MA, van der Zon AM: Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig Liver Dis 2007, 39, 733-739. (Pubitemid 47053808)
2. von Lampe B, Barthel B, Coupland SE: Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 2000, 47, 63-73. (Pubitemid 30430413)
3. Medina C, Radomski MW: Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 2006, 318, 933-938. (Pubitemid 44268297)
4. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17, 464-516.
5. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005, 41, 1-7.
6. Truelove SC, Witts LJ: Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955, 2, 1041-1048.
7. Faveeuw C, Preece G, Ager A: Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 2001, 98, 688-695.
8. Delclaux C, Delacourt C, D'Ortho MP: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Resp Mol Cell Biol 1996, 14, 288-229.
9. Di Sebastiano P, di Mola FF, Artese L: Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis. Digestion 2001, 63, 234-239. (Pubitemid 32646303)
10. Naito Y, Takagi T, Kuroda M: An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflam Res 2004, 53, 462-468. (Pubitemid 39382169)
11. Santana A, Medina C, Paz-Cabrera MC: Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. World J Gastroenterol. 2006, 12, 6464-6472. (Pubitemid 44742583)
12. Sykes AP, Bhogal R, Brampton C: The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzensulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther 1999, 13, 1535-1542. (Pubitemid 29516269)
13. Louis E, Ribbens C, Godon A: Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000, 120, 241-246. (Pubitemid 30304217)
14. Gao Q, Meijer MJ, Kubben FJ: Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig Liver Dis 2005, 37, 584-592. (Pubitemid 44356072)
15. Manfredi MA, Zurakowski D, Rufo PA: Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2008, 14, 1091-1096.
16. Wang YD, Tan XY, Zhang K: Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis. Mediators Inflamm 2009, 275072. Epub 2009, 9.
17. Kofla-Dlubacz A, Matusiewicz M, Krzystek-Korpacka M, Iwanczak B: Correlation of MMP-3 and MMP-9 with Crohn's Disease Activity in Children. Dig Dis Sci 2012, 57, 706-712.
18. Tezvergil-Mutluay A, Agee KA, Hoshika T: The requirement of zinc and calcium ions for functional MMP activity in demineralized dentin matrices. Dent Mater 2010, 26, 1059-1067.
19. Kato MT, Leite AL, Hannas AR: Effect of iron on matrix metalloproteinase inhibition and on the prevention of dentine erosion. Caries Res 2010, 44, 309-316.
20. Fagerberg UL, Lööf L, Myrdal U: Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005, 40, 450-455. (Pubitemid 40489572)
21. Konikoff MR, Denson LA: Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12, 524-534.
22. Vermeire S, Van Assche G, Rutgeerts P: Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006, 55, 426-431. (Pubitemid 43268284)
23. Vermeire S, Van Assche G, Rutgeerts P: The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005, 2, 580-586.
24. Dollery CM, McEwan JR, Hanney AM: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 77, 863-868.
25. Tchetverikov I, Lard LR, DeGroot J: Matrix metalloproteinases-3, -8, -9 as markers of disease activity and joint damage progression in early rheumatoid arthritis. Ann Rheum Dis 2003, 62, 1094-1099. (Pubitemid 37323575)
26. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression, Nature Rev Cancer 2002, 2, 161-174. (Pubitemid 37328786)